Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1075 to 1124 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
538\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h (hnrnp h). [source:swissprot;acc:p31943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7301.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7644.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04699\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein-tyrosine phosphatase beta precursor (ec 3.1.3.48) (r-ptp- beta). [source:swissprot;acc:p23467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10603.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12069.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13825\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
539\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba138e2.1.2 (formin-binding protein 17 (fbp17), isoform 2). [source:sptrembl;acc:q96lh6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7993.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8368.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04697\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thymus-specific serine protease precursor (ec 3.4.-.-). [source:swissprot;acc:q9nqe7]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
10603.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
12069.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13825\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
540\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gk001 protein. [source:refseq;acc:nm\_020198]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna splicing factor prp17 (hprp17) (eh-binding protein 3) (ehb3). [source:swissprot;acc:o60508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7937.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8310.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04694\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
541\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calsyntenin-2 precursor. [source:swissprot;acc:q9h4d0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10600.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12065.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13819\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily a member 4. [source:swissprot;acc:q8ww22]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8574.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8976.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04686\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
542\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h' (hnrnp h') (ftp-3). [source:swissprot;acc:p55795]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7305.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7647.16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04683\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rac-alpha serine/threonine kinase (ec 2.7.1.-) (rac-pk-alpha) (protein kinase b) (pkb) (c-akt). [source:swissprot;acc:p31749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3889.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4426.74\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13819\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
543\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calsyntenin-3 precursor. [source:swissprot;acc:q9bqt9]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10599.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12064.7\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 4-kinase type-ii beta; likely ortholog of mouse phosphatidylinositol 4-kinase type 2 beta. [source:refseq;acc:nm\_018323]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8159.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8541.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04681\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
544\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pp1201 protein. [source:refseq;acc:nm\_022152]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7723.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8085.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0468\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rac-gamma serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-gamma) (protein kinase akt-3) (protein kinase b, gamma) (pkb gamma) (stk-2). [source:swissprot;acc:q9y243]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3889.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4426.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13819\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
545\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 4-kinase type ii. [source:refseq;acc:nm\_018425]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8159.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8540.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04676\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rac-beta serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-beta) (protein kinase akt-2) (protein kinase b, beta) (pkb beta). [source:swissprot;acc:p31751]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3889.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4426.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13819\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
546\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthetase (ec 6.3.4.4) (imp--aspartate ligase) (adss) (ampsase). [source:swissprot;acc:p30520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8451.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8845.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0467\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein t86. [source:swissprot;acc:o00488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4052.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4612.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13812\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
547\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8727.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9135.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04669\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
werner helicase interacting protein isoform 1; putative helicase ruvbl; werner helicase interacting protein. [source:refseq;acc:nm\_020135]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5291.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6020.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13762\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
548\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8447.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8841.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04668\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8268.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9405.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13759\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
549\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichol-phosphate mannosyltransferase (ec 2.4.1.83) (dolichol- phosphate mannose synthase) (dolichyl-phosphate beta-d- mannosyltransferase) (mannose-p-dolichol synthase) (mpd synthase) (dpm synthase). [source:swissprot;acc:o60762]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5865.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6671.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13731\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
imp2 inner mitochondrial membrane protease-like; inner mitochondrial membrane peptidase 2 like. [source:refseq;acc:nm\_032549]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7823.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8187.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04658\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
550\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f8 (ec 1.14.14.1) (cypivf8). [source:swissprot;acc:p98187]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8132.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8511.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04657\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prohibitin. [source:swissprot;acc:p35232]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5773.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6563.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13687\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
551\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
repressor of estrogen receptor activity; b-cell associated protein. [source:refseq;acc:nm\_007273]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sterol regulatory element binding protein-2 (srebp-2) (sterol regulatory element-binding transcription factor 2). [source:swissprot;acc:q12772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7739.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8100.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04657\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
552\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage stimulation factor, 64 kda subunit (cstf 64 kda subunit) (cf-1 64 kda subunit). [source:swissprot;acc:p33240]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15427.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13572.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13663\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sterol regulatory element binding protein-1 (srebp-1) (sterol regulatory element-binding transcription factor 1). [source:swissprot;acc:p36956]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7739.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8100.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04657\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
553\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec6. [source:swissprot;acc:o60645]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8385.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8776.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04655\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tgf beta-inducible nuclear protein 1; hairy cell leukemia protein 1. [source:refseq;acc:nm\_014886]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3853.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4379.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13651\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
554\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
axonemal dynein light intermediate polypeptide 1 (inner dynein arm light chain, axonemal) (hp28). [source:swissprot;acc:o14645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7296.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7635.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04652\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna cleavage complex ii protein clp1. [source:swissprot;acc:q92989]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14830.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13050.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13641\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
555\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7305.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7644.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04642\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13615\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
556\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein interacting protein (wasp interacting protein) (prpl-2 protein). [source:swissprot;acc:o43516]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8139.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8517.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04642\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
557\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13615\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7305.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7644.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04642\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
558\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f12 (ec 1.14.14.1) (cypivf12). [source:swissprot;acc:q9hcs2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8130.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8507.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0464\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13615\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
559\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8069.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8443.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04637\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
560\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7980.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8350.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04636\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cystathionine beta-synthase (ec 4.2.1.22) (serine sulfhydrase) (beta-thionase). [source:swissprot;acc:p35520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5480.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6222.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13536\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
561\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lifeguard; kiaa0950 protein. [source:refseq;acc:nm\_012306]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7755.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8115.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04635\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein rhoc (h9). [source:swissprot;acc:p08134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5480.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6222.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13536\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
562\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 3 (vesicle docking protein sec34 homolog) (p94). [source:swissprot;acc:q96jb2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7561.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7911.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04627\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thiosulfate sulfurtransferase (ec 2.8.1.1) (rhodanese). [source:swissprot;acc:q16762]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5480.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6222.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13536\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/